Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype

Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype

Detalhes bibliográficos
Principais autores:	Song, W, Stuckey, D, Dyer, E, Wells, D, Harding, SE, Carr, C, Clarke, K, Marston, S
Formato:	Conference item
Publicado em:	2009

Registros relacionados

PHENOTYPE OF THE ACTC E99K TRANSGENIC MOUSE REPRODUCES HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS
por: Song, W, et al.
Publicado em: (2010)

Mouse Model of Familial Hypertrophic Cardiomyopathy with E99K ACTC Mutation Recapitulates Many Features of Hypertrophic Cardiomyopathy in Patients
por: Song, W, et al.
Publicado em: (2008)

Investigation of a mouse model of familial DCM with ACTC E361G mutation
por: Song, W, et al.
Publicado em: (2008)

In vitro motility studies of HCM and DCM mutations in cardiac muscle actin
por: Dyer, E, et al.
Publicado em: (2007)

Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.
por: Song, W, et al.
Publicado em: (2011)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
por: Carballo, S, et al.
Publicado em: (2004)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
por: Carballo, S, et al.
Publicado em: (2008)

ATTR Gene Variants in HCM
por: Anthony J. Kanelidis, MD, et al.
Publicado em: (2024-03-01)

HCM and DCM mutations in thin filament proteins have opposite effects on in vitro motility
por: Marston, S, et al.
Publicado em: (2002)

The HCM-associated cardiac Troponin T mutation K280N causes reduced responsiveness to protein kinase A
por: Van Der Velden, J, et al.
Publicado em: (2012)

Functional investigation of troponin with the homozygous HCM mutation, TNNT2 K280N, obtained from an explanted heart
por: Bayliss, C, et al.
Publicado em: (2012)

HCM2010 : highway capacity manual /
por: National Research Council (U.S.). Transportation Research Board
Publicado em: (2010)

Sarcomeric versus Non-Sarcomeric HCM
por: Felice Borrelli, et al.
Publicado em: (2023-06-01)

HCM and DCM mutations in thin filament proteins have opposite effects on regulation of contractility in vitro
por: Redwood, C, et al.
Publicado em: (2003)

HCM and DCM mutations in cardiac thin filament proteins have opposite effects on the regulation of contractility in vitro
por: Redwood, C, et al.
Publicado em: (2003)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
por: Neubauer, S, et al.
Publicado em: (2019)

The HCM-Associated Cardiac Troponin T Mutation K280N Increases the Energetic Cost of Tension Generation in Human Cardiac Myofibrils
por: Ferrara, C, et al.
Publicado em: (2013)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
por: Neubauer, S, et al.
Publicado em: (2019)

Leaders’ learning orientation and the HCM-turn in call centres
por: Dorina Gnauer
Publicado em: (2013-06-01)

Ischaemia as a cause of LVOT gradient reversal in HCM
por: Camelia Demetrescu, et al.
Publicado em: (2017-10-01)

Firms’ satisfaction with service quality of the HCM City Tax
por: Lê Bảo Lâm, et al.
Publicado em: (2021-03-01)

Fabry Disease Mistaken for HCM: The Diagnostic Impact of T1 Mapping
por: Stefano Censi, MD, et al.
Publicado em: (2024-01-01)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
por: Redwood, C, et al.
Publicado em: (2001)

MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM
por: Mengmeng Li, et al.
Publicado em: (2018-06-01)

Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits
por: James G.W. Smith, et al.
Publicado em: (2018-11-01)

Asymmetrically Clipped Optical Hadamard Coded Modulation (ACO-HCM)
por: Henrik Schulze, et al.
Publicado em: (2023-01-01)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
por: Dass, S, et al.
Publicado em: (2012)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
por: Carballo, S, et al.
Publicado em: (2005)

Age and strain related aberrant Ca(2+) release is associated with sudden cardiac death in the ACTC E99K mouse model of hypertrophic cardiomyopathy
por: Rowlands, C, et al.
Publicado em: (2017)

Applicability of HCM LOS criteria for Malaysian single-carriageway performance analysis
por: Md. Ithnan, Mohd. Izuddin
Publicado em: (2007)

Applicability of HCM LOS criteria for Malaysian single-carriageway performance analysis /
por: 355159 Mohd. Izuddin Md. Ithnan, et al.
Publicado em: (2007)

Multilevel modelling for decision support in hypertrophic cardiomyopathy in the SMASH-HCM project
por: Alpo Olavi Värri, et al.
Publicado em: (2024-05-01)

HCM‐based indoor optical wireless communications: Timing and data recovery
por: Masoud Johar, et al.
Publicado em: (2023-10-01)

Methodology for analysing capacity and level of service for signalized intersections (HCM 2000)
por: Nedevska Ivana, et al.
Publicado em: (2016-01-01)

Việc làm và trẻ lang thang tại TP.HCM
por: Lê Thị Mỹ Hiền
Publicado em: (2005-03-01)

A complex unit for a complex disease: the HCM-Family Unit
por: Olga Vriz, et al.
Publicado em: (2021-12-01)

Maturity of IT systems supporting communication processes in HCM in a modern organization
por: Andrzej Sołtysik
Publicado em: (2016-10-01)

Influence of Clinical Aspects and Genetic Factors on Feline HCM Severity and Development
por: Victoria Korobova, et al.
Publicado em: (2024-05-01)

Characterisation and distribution of a cryptic Salmonella typhi plasmid pHCM2.
por: Kidgell, C, et al.
Publicado em: (2002)

Interaction analyses elucidate the pathophysiology of HCM-causing missense mutations in cardiac myosin binding protein-C.
por: Moolman-Smook, J, et al.
Publicado em: (2001)